[Abstract] [Full Text PDF] (in Japanese / 8393KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 55(4): 385-395, 1954


Original article

STUDIES ON INTRAARTERIAL APPLICATION OF METHYL-(BIS-β-CHLOROETHYL)-AMINE-N-OXIDE AND ISOAMYL-(BIS-β-CHLOROETHYL)-AMINE-N-OXIDE AGAINST MALIGNAT TUMOR

I. Surgical Department, Tokyo University School of Medicine (Director: Prof. K. Shimizu)

Takuji NAKAMURA

According to results obtained from animal experiments, in which intracarotid injection of a large amount of methyl-(bis-β-chloroethyl)-amine-N-oxide (NMO), isoamyl-(bis-β-chloroethyl)-amine-N-oxide (NMO), isoamyl-(bis-β-chloroethyl)-amine-N-oxide (A-NMO), and methyl-(bis-β-chloroethyl)-amine-N-oxide (NMO), isoamyl-(bis-β-chloroethyl)-amine-N-oxide (A-NMO), and methyl-(bis-β-chloroethyl)-amine (NM) was performed in cats, NMO and A-NMO can be safely applied for intracarotid injection without cerebral damage which is often observed in cases of NM injection.
Against malignant tumors of man intraarterial injection of NMO and A-NMO was performed, which showed much better effect than intravenous injection.
Before and during the therapy, serial needle biopsy was performed in order to trace cytological changes of tumor by smear preparate. The cytrological changes, namely, abnormal mitosis, appearance of giant cell, vaculolar degeneration, nuclear deformity, etc., which may be due to disturbance of mitosis, were observed.
NMO was injected into the femoral artery of rat before tumor-formation of Yoshida Sarcoma which was transplanted subcutaneously in the calf region. When inhibitory effect of intraarterial injection against tumor-formation with that of intravenous injection, the former is far more excellent than the latter.
Considering the marked difference of the effect mentioned above, it is thought that injecthd NMO is not absorbed gradually into tissue remaining in circulating blood, but is absorbed rapidly.
Accordingly, for the purpose of postoperative control of recurrence or palliative treatment, intraarterial application of NMO, and A-NMO as tumor-growth retarding agents is more effective than intravenous application.
(author's abstract)


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.